Showing results (1-10 of 7,836) with videos related to
Sort By:
Pageof 784
Advances in Experimental Medicine and Biology|September 8, 2018
Computational Inferring of Risk Subpathways Mediated by Dysfunctional Non-coding RNAsYanjun Xu, Yunpeng Zhang, Xia LiScientific Reports|December 6, 2013
Network analysis reveals functional cross-links between disease and inflammation genesYunpeng Zhang, Huihui Fan, Juan Xu, et al.Oncotarget|July 31, 2016
MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAsJunwei Han, Siyao Liu, Yunpeng Zhang, et al.Oncotarget|March 26, 2016
Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progressionYunpeng Zhang, Yanjun Xu, Feng Li, et al.Oncotarget|September 1, 2016
Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancersYunpeng Zhang, Yanjun Xu, Li Feng, et al.Journal of Translational Medicine|July 9, 2021
Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanomaJingwen Wang, Feng Li, Yanjun Xu, et al.Oncotarget|September 17, 2016
Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologiesXinrui Shi, Yanjun Xu, Chunlong Zhang, et al.Journal of Translational Medicine|June 21, 2022
Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to gliomaChunlong Zhang, Jiaxin Zhao, Wanqi Mi, et al.Biomed Research International|April 16, 2015
Identification of subtype specific miRNA-mRNA functional regulatory modules in matched miRNA-mRNA expression data: multiple myeloma as a caseYunpeng Zhang, Wei Liu, Yanjun Xu, et al.Oncotarget|February 3, 2017
LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologiesYanjun Xu, Feng Li, Tan Wu, et al.Pageof 784